The oversubscribed raise was led by investment platform Wealth Club alongside existing backers Deepbridge Capital and Boundary Capital.
"Glyconics offers a transformational, cost-efficient, rapid and non-invasive approach to diabetes screening – and it is testament to this pioneering device and all at Team Glyconics that this raise was so significantly over-subscribed. We are delighted to be continuing with our existing investors and, of course, welcome our new investors from Wealth Club and other private investors to the fold."
The funding round was co-led by Pentech and Outward to support infrastructure development and team expansion.
"When raising capital, VCs are obliged to undertake a countless number of time-consuming, long-winded and expensive processes. This deter many prospective managers from raising a fund, and therefore prevent many founders from getting funded."
The funding follows regulatory approval for its plant-based egg products in Europe and commercial milestones for its cultivated meat division.
"We are delighted to have partnered with CEO, Josh Tetrick the team at Eat Just Inc. With the demand for plant based products soaring they offer a viable alternative to conventionally-produced egg products and are offering impressive returns for all stakeholders. This is a prime example of the sort of business we will be working with at AIV Capital. One with a strong management team with a demonstrated edge in the space they operate in."
